/ Blog

Latest Insights & Perspectives

Blogs

Biotech insights, research highlights and more

Expert knowledge, biotech insights, and updates from the Ymmunobio team

Bladder cancer treatment has improved, but patients still face high recurrence, limited options, and major gaps in durability and access.

We examine how modern ADC platforms improve payload delivery, enhance tumor selectivity, and expand treatment options across solid tumors.

This post breaks down key resistance mechanisms in solid tumors and highlights why overcoming them is essential for more effective

This article explores how tumor-exclusive antigens enable more precise, less toxic cancer therapies and open new paths for targeted drug